Japanese Pharmaceutical Company Touts Ivermectin’s ‘Antiviral Effect’ Against COVID-19

  • by:
  • 03/02/2023

Japanese trading and pharmaceutical company Kowa Co. Ltd. said Monday that ivermectin shows an “antiviral effect” against the omicron variant and others. 

The statement was based on joint, non-clinical trials the company has been running with Tokyo’s Kitasato University, Just the News reports

It is no secret that the drug is extremely controversial. It is not approved for use in treating the virus in Japan, and in the U.S., the FDA continues to caution against its use. 

While the FDA argues there have been a number of cases in which people were hospitalized after self-medicating with the drug, there have also been several cases of it being used to successfully treat COVID-19 in unvaccinated and vaccinated patients. 

Ivermectin is currently being studied in the United Kingdom in a trial through Oxford University. 

Image: by is licensed under
ADVERTISEMENT

Opinion

View All

BREAKING: Iraq launches rockets towards US military base in Syria

The rockets were launched from the Iraqi town of Zummar....

X fights Australia over demands to remove posts showing stabbing of Christian bishop

"We will robustly challenge this unlawful and dangerous approach in court."...

UN agency encourages pro-Gaza civil disobedience in US

This comes at a time when there have been numerous examples of Pro-Gaza activists blocking traffic in...

ERIN ELMORE: 911 outages reported in Nebraska, Nevada, South Dakota and Texas

“The fact is, the PRC’s [People’s Republic of China] targeting of our critical infrastructure is both...